Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


EMA Waves Goodbye To HTA Network As Collaboration Framework Enters New Phase

Executive Summary

A report published by the European Medicines Agency highlights milestones reached under its collaboration with EUnetHTA over recent years and outlines areas for further development once the initiative changes hands under the new HTA Regulation.

You may also be interested in...

European HTA Network Rejects Industry Criticism Of Joint Clinical Assessments

EUnetHTA 21, the EU health technology assessment network that will soon hang up its hat has defended the methodologies it developed to support the EU HTA Regulation in the wake of criticism from industry.

EU HTA Regulation: Companies Want Bigger Role In Shaping Assessments

A bigger role for companies in the scoping process for the imminent EU-level joint clinical assessments is essential for patient access, according to industry.

Germany’s G-BA To Act As Coordinator In New EMA-HTA Parallel Scientific Advice Approach

A new format for obtaining parallel scientific advice from the European Medicines Agency and national health technology assessment bodies in Europe is coming soon.

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts